News
7.9.23

TOPADUR has been selected as a TOP 100 Scale-up 2023 with unicorn potential

Zurich-Schlieren, Switzerland, 7 September 2023

We are thrilled to announce that TOPADUR Pharma AG has once again been recognized as one of Switzerland's top 25 scale-up companies.

This achievement is a demonstration to our team's dedication and our partners' support.

We are grateful for this recognition and remain committed to pushing the boundaries of innovation in the years to come.

Please check out the link below.

Download DocumentDokument herunterladenTOP 25 scale-ups 2023TOP 25 scale-ups 2023
6.6.24
Press Release

Topadur Pharma AG and Oshen Holdings SA sign a co-development agreement

Topadur Pharma AG and Oshen Holdings SA Partner to Develop a Treatment for Alopecia

Read more
3.7.20
Press Release

Dr. Daniel L. Vasella new member of the Board of Directors

The shareholders of the company elected today Dr. Daniel L. Vasella, as new member to the Board of Directors.

Read more
8.9.22
News

TOPADUR has been selected as a TOP 100 Scale-up 2022 with unicorn potential

We are proud to be recognized as one of Switzerland's most promising scale-ups in 2022.

Read more